Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate

Go back to Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
Novavax, Inc. (NASDAQ: NVAX) Delayed: 9.39 +0.39 (4.33%)
Previous Close $9.00    52 Week High $9.23 
Open $8.81    52 Week Low $1.16 
Day High $9.59    P/E N/A 
Day Low $8.81    EPS $-0.30 
Volume 1,359,620